Brief: Cutia Therapeutics Says Q3 Revenue Of Group's Commercialized Products RMB 30.5 Mln
06/11/2023 10:18
Nov 6 (Reuters) - Cutia Therapeutics 2487.HK :
* Q3 REVENUE OF GROUP'S COMMERCIALIZED PRODUCTS RMB 30.5
MILLION,
UP 595%
Source text for Eikon: ID:
Further company coverage: 2487.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cutia Therapeutics
See all newsBrief: Cutia Therapeutics To Implement Share Repurchase Program From Oct 2 To Dec 31
Brief: Cutia Therapeutics Says Cu-40102 Bags Marketing Approval From Macao Pharmaceutical Administration Bureau
Brief: Cutia Therapeutics Says Nmpa Accepts Biologics License Application For Cu-20101
Brief: Cutia Therapeutics Posts HY Loss Of RMB180.4 MLN
Brief: Cutia Therapeutics Says CU-30101 Obtains Drug Marketing Authorization By NMPA China